BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3318421)

  • 1. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of nabumetone in United States clinical trials.
    Jackson RE; Mitchell FN; Brindley DA
    Am J Med; 1987 Oct; 83(4B):115-20. PubMed ID: 3318422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabumetone: a clinical appraisal.
    Helfgott SM
    Semin Arthritis Rheum; 1994 Apr; 23(5):341-6. PubMed ID: 8036523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone: new preparation. Just another NSAID.
    Prescrire Int; 2000 Apr; 9(46):43-6. PubMed ID: 11503785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term U.S. study--a report on outcome and tolerance.
    Fleischmann R
    Eur J Rheumatol Inflamm; 1991; 11(3):50-3. PubMed ID: 1365481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nabumetone (Relifex)--another NSAID.
    Drug Ther Bull; 1988 May; 26(11):41-3. PubMed ID: 3289871
    [No Abstract]   [Full Text] [Related]  

  • 9. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy.
    Roth SH
    Am J Med; 1987 Oct; 83(4B):25-30. PubMed ID: 3318424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nabumetone--a new NSAID.
    Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
    Morgan GJ; Poland M; DeLapp RE
    Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis.
    Fleischmann RM
    J Rheumatol Suppl; 1992 Nov; 36():32-40. PubMed ID: 1474533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute rheumatic-articular diseases with nabumetone].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1990 Aug 15-31; 134(3-4):181-5. PubMed ID: 2147618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis.
    Lanier BG; Turner RA; Collins RL; Senter RG
    Am J Med; 1987 Oct; 83(4B):40-3. PubMed ID: 3318427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nabumetone: a single-center three-week comparison with placebo in the treatment of rheumatoid arthritis.
    Turner RA; Brindley DA; Mitchell FN
    Am J Med; 1987 Oct; 83(4B):36-9. PubMed ID: 3318426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study.
    Blechman WJ
    Am J Med; 1987 Oct; 83(4B):70-3. PubMed ID: 3318432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs for the new decade--nabumetone?
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel study.
    Vasey FB; Germain BF; Espinoza LR; Box P; Bockow BI; Lipani JA; Mullen BJ; Brodsky AL; Fleischmann RM; Fogari RA
    Am J Med; 1987 Oct; 83(4B):55-9. PubMed ID: 3318430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and improved safety--a new anti-arthritic agent.
    Irani M
    Eur J Rheumatol Inflamm; 1991; 11(3):43-9. PubMed ID: 1365480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.